Last quarter (Q3 2023), Agile Therapeutics's total revenue was $6.66M, an increase of 121.92% from the same quarter last year. In Q3, Agile Therapeutics's net income was $-799.00K. See Agile Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 17.67M	$ 10.88M	$ 4.10M	$ 749.00K	$ 0.00	$ 0.00
Cost of Revenue	$ 2.83M	$ -6.84M	$ -10.72M	$ 282.00K	$ 0.00	$ 0.00
Gross Profit	$ 11.53M	$ 4.05M	$ -6.62M	$ 467.00K	$ 0.00	$ 0.00
Operating Expense	$ 15.81M	$ -56.60M	$ -64.39M	$ 49.52M	$ 18.86M	$ 18.52M
Operating Income	$ -22.71M	$ -41.43M	$ -71.00M	$ -49.05M	$ -18.86M	$ -18.52M
Net Non Operating Interest Income Expense	$ -1.46M	$ -3.05M	$ -3.89M	$ -2.80M	$ 252.00K	$ -750.00K
Other Income Expense	$ -30.72M	$ -14.40M	$ 3.83M	-	-	$ -990.00K
Pretax Income	$ 8.24M	$ -30.09M	$ -71.07M	$ -51.85M	$ -18.61M	$ -20.26M
Tax Provision	-	$ -4.67M	-	$ 0.00	$ 0.00	$ -477.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 8.24M	$ -25.41M	$ -71.07M	$ -51.85M	$ -18.61M	$ -19.78M
Basic EPS	$ -2.49	$ -1.18	$ -38.50	$ -24.40	$ -0.38	$ -0.58
Diluted EPS	$ -2.49	$ -1.18	$ -38.50	$ -24.40	$ -0.38	$ -0.58
Basic Average Shares	$ 27.24M	$ 21.61M	$ 1.94M	$ 2.12M	$ 49.43M	$ 34.32M
Diluted Average Shares	$ 27.24M	$ 21.61M	$ 1.94M	$ 2.12M	$ 49.43M	$ 34.32M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 18.63M	$ -63.44M	$ -75.11M	$ 49.80M	$ 18.86M	$ 18.52M
Net Income From Continuing And Discontinued Operation	$ 8.24M	$ -25.41M	$ -71.07M	$ -51.85M	$ -18.61M	$ -19.78M
Normalized Income	$ -3.64M	-	-	$ -51.85M	$ -18.61M	$ -18.81M
Interest Expense	-	-	-	$ 3.11M	$ 0.00	$ 1.12M
EBIT	$ 9.76M	$ -28.12M	$ -69.54M	$ -48.74M	$ -18.61M	$ -19.14M
EBITDA	$ 10.14M	$ -26.58M	$ -67.31M	$ -48.47M	$ -18.44M	$ -19.12M

Currency in USD

Agile Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing